xiangde luo
xiangdeluo
- United States of America
- Stanford University
- Department of Radiation Oncology
- Website
Statistics
- Member for 6 years, 1 month
- 24 challenge submissions
Activity Overview
IDRiD
Challenge UserThis challenge evaluates automated techniques for analysis of fundus photographs. We target segmentation of retinal lesions like exudates, microaneurysms, and hemorrhages and detection of the optic disc and fovea. Also, we seek grading of fundus images according to the severity level of DR and DME.
Thyroid Nodule Segmentation and Classification
Challenge UserThe main topic of this TN-SCUI2020 challenge is finding automatic algorithms to accurately classify the thyroid nodules in ultrasound images. It will provide the biggest public dataset of thyroid nodule with over 4500 patient cases from different ages, genders, and were collected using different ultrasound machines. Each ultrasound image is provided with its ground truth class (benign or maglinant) and a detailed delineation of the nodule. This challenge will provide a unique opportunity for participants from different backgrounds (e.g. academia, industry, and government, etc.) to compare their algorithms in an impartial way.
CADA
Challenge UserCerebral aneurysms are local dilations of arterial blood vessels caused by a weakness of the vessel wall. Subarachnoid hemorrhage (SAH) caused by the rupture of a cerebral aneurysm is a life-threatening condition associated with high mortality and morbidity. The mortality rate is above 40%, and even in case of survival cognitive impairment can affect patients for a long time. Major goals in image analysis are the detection and risk assessment of aneurysms. We, therefore, subdivided the challenge into three categories. The first task is finding the aneurysm; the second task is the accurate segmentation to allow for a longitudinal assessment of the development of suspicious aneurysms. The third task is the estimation of the rupture risk of the aneurysm.
WSSS4LUAD
Challenge UserThe WSSS4LUAD dataset contains over 10,000 patches of lung adenocarcinoma from whole slide images from Guangdong Provincial People's Hospital and TCGA with image-level annotations. The goal of this challenge is to perform semantic segmentation for differentiating three important types of tissues in the WSIs of lung adenocarcinoma, including cancerous epithelial region, cancerous stroma region and normal region. Paticipants have to use image-level annotations to give pixel-level prediction.
LNQ2023
Challenge UserAccurate lymph node size estimation is critical for staging cancer patients, initial therapeutic management, and in longitudinal scans, assessing response to therapy. Current standard practice for quantifying lymph node size is based on a variety of criteria that use unidirectional or bidirectional measurements on just one or a few nodes, typically on just one axial slice. But humans have hundreds of lymph nodes, any number of which may be enlarged to various degrees due to disease or immune response. While a normal lymph node may be approximately 5mm in diameter, a diseased lymph node may be several cm in diameter. The mediastinum, the anatomical area between the lungs and around the heart, may contain ten or more lymph nodes, often with three or more enlarged greater than 1cm. Accurate segmentation in 3D would provide more information to evaluate lymph node disease.
REport Generation in pathology using Pan-Asia Giga-pixel WSIs
Challenge UserThis project focuses on advancing automated pathology report generation using vision-language foundation models. It addresses the limitations of traditional NLP metrics (e.g., BLEU, METEOR, ROUGE) by emphasizing clinically relevant evaluation. The initiative includes standardized datasets, expert comparisons, and medical-domain-specific metrics to assess model performance. It also explores the integration of generated reports into diagnostic workflows with clinical feedback. To support fairness and generalizability, the challenge dataset comprises ~20,500 cases from six medical centers in Korea, Japan, India, Turkey, and Germany, promoting multicultural and multiethnic medical AI development.